Pulse Biosciences (PLSE) Free Cash Flow (2020 - 2025)

Pulse Biosciences has reported Free Cash Flow over the past 6 years, most recently at -$14.9 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$14.9 million for Q4 2025, down 63.33% from a year ago — trailing twelve months through Dec 2025 was -$54.4 million (down 49.68% YoY), and the annual figure for FY2025 was -$54.4 million, down 49.68%.
  • Free Cash Flow for Q4 2025 was -$14.9 million at Pulse Biosciences, down from -$13.2 million in the prior quarter.
  • Over the last five years, Free Cash Flow for PLSE hit a ceiling of -$6.6 million in Q1 2023 and a floor of -$16.5 million in Q2 2021.
  • Median Free Cash Flow over the past 5 years was -$11.2 million (2021), compared with a mean of -$11.3 million.
  • Biggest five-year swings in Free Cash Flow: tumbled 109.21% in 2021 and later soared 57.69% in 2023.
  • Pulse Biosciences' Free Cash Flow stood at -$12.4 million in 2021, then surged by 35.53% to -$8.0 million in 2022, then grew by 14.75% to -$6.8 million in 2023, then tumbled by 33.3% to -$9.1 million in 2024, then crashed by 63.33% to -$14.9 million in 2025.
  • The last three reported values for Free Cash Flow were -$14.9 million (Q4 2025), -$13.2 million (Q3 2025), and -$12.8 million (Q2 2025) per Business Quant data.